NCT01318343

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of single treatment vs. multiple treatments of CoolSculpting™ by Zeltiq™ Aesthetics for non-invasive cooling of subcutaneous fat using the eZ App 8 large applicator on the abdomen for fat layer reduction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 18, 2011

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

March 31, 2015

Status Verified

March 1, 2015

Enrollment Period

8 months

First QC Date

March 17, 2011

Last Update Submit

March 30, 2015

Conditions

Keywords

CryolipolysisAbdominal FatAdipose TissueFat ReductionNon Invasive

Study Arms (3)

Treatment Group 1

Eight (8) subjects will receive one (1) treatment with the eZ8 Large Applicator.

Treatment Group 2

Eight (8) subjects will receive two (2) treatments two (2) months apart with the eZ8 Large Applicator.

Treatment Group 3

Four (4) subjects will receive one (1) treatment, six (6) months after the previous treatment with the eZ App 8 large applicator to the abdomen. This is the same applicator that is being evaluated in this study. These subjects have been treated on-site at the Laser \& Skin Surgery Center of New York by the study doctor.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of 20 subjects, ages 18-65 years, who have clearly visible fat in the lower abdomen and are appropriate candidates as per the Study Doctor's physical examination.

You may qualify if:

  • Male or female between the ages of 18 and 65 years of age.
  • Clearly visible fat on an area of the lower abdomen appropriate for treatment with the non-invasive Zeltiq cooling device.
  • Not had weight change fluctuations exceeding 5 pounds in the preceding 6 months.
  • Read and sign a written informed consent form.

You may not qualify if:

  • Had liposuction, or another surgical procedure(s) or mesotherapy (injections of minute natural extracts, drugs and other agents into the skin to eliminate fat deposits in cellulite) in area of intended treatment within the past 2 years.
  • Known history of injections into the abdomen (e.g., cortisone) within the past 6 months.
  • Known history of cryoglobulinemia (abnormal blood proteins that thicken in cold temperatures), cold urticaria (large, allergic hives that occur when the skin is exposed to cold), or paroxysmal cold hemoglobinuria (sudden development of red blood cell breakdown causing hemoglobin \[protein compound in blood\] in the urine).
  • Used diet pills within the past 6 months.
  • Taking amino- or theophylline for asthma.
  • You are unable or unwilling to comply with the study requirements.
  • Any dermatological conditions or scars within the location of the treatment site that may interfere with the treatment or evaluation.
  • Currently enrolled in a clinical study of any other unapproved investigational drug or device.
  • Pregnant or intending to become pregnant in the next 9 months.
  • Breastfeeding or have been breastfeeding in the past 9 months.
  • Any other condition that would, in the professional opinion of the study doctor, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laser & Skin Surgery Center of New York

New York, New York, 10016, United States

Location

Study Officials

  • Roy G Geronemus, MD

    Laser & Skin Surgery Center of New York

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 17, 2011

First Posted

March 18, 2011

Study Start

March 1, 2011

Primary Completion

November 1, 2011

Study Completion

February 1, 2012

Last Updated

March 31, 2015

Record last verified: 2015-03

Locations